🇺🇸 FDA

Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6063138

Method and apparatus for the formation of particles

Bradford Particle Design Limited · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063371

Pharmaceutical compositions comprising a soluble interleukin-4 receptor

The United States of America as represented by the Secretary of the Army · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060311

Retinoid suppression of ventricular muscle cell hypertrophy

The Regents of the University of California · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060582

Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-r

The Board of Regents of the University of Texas System · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060515

Treatment of skin conditions by use of PPAR.alpha. activators

The Regents of the University of California · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060500

Suppression, by 5-lipoxygenase inhibitors, of bone resorption

The Board of Regents of the University of Texas System · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060310

Transcription factor decoy and tumor growth inhibitor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060270

Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro ki

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6060238

Method and composition for regulating apoptosis

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057298

Keratin K1 expression vectors and methods of use

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057104

Disruption of the mammalian Rad51 protein and disruption of proteins that associate with m

Lexicon Genetics, Inc. · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6056952

Selective elimination of T cells that recognize specific preselected targets

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057311

Benzodiazonine derivatives binding to cholecystokinin or gastrin receptors

The James Black Foundation Limited · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057341

Bi-aromatic dibenzofuran derivatives and their use in human and veterinary medicine and in

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057346

Inhibition of retroviral LTR promoters by calcium response modifiers

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6057421

Variable heavy and light chain regions of murine monoclonal antibody 1F7

Immpheron, Inc. · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054433

Methods and compositions for stimulating tissue growth and epithelial moisturization

The Regents of the University of California · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054427

Methods and compositions for optimization of oxygen transport by cell-free systems

The Regents of the University of California · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054486

Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-d

UNITED TECHNOLOGY CORPORATION · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054485

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6054442

Methods and compositions for modulation and inhibition of telomerase in vitro

The Board of Regents of the University of Texas System · Granted Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6051230

Compositions for targeting the vasculature of solid tumors

The Board of Regents of the University of Texas System · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6051229

Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions

The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6051227

Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling

The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired